Loading...

CAMP CAMP4 THERAPEUTICS CORP Capital Structure Changes 8-K Filing

CMP4

CMP

CAMP4 THERAPEUTICS CORP

(CAMP)

2024 8-K

New Data Release

Financial Results

Director Appointment

Financial Results Update

Corporate Update

Lease Agreement Update

Stock Offering Update

Collaboration Agreement

Financial Results Announced

Toxicology Studies Initiated

Securities Agreement

Financial Results Announcement

Product Expansion

Financial Statements

Financial Results

Board Appointments

Corporate Presentation

Financial Results

External Links:

CAMP4 Therapeutics Corporation filed a fifth amended and restated certificate of incorporation and amended bylaws in connection with its IPO, authorizing 175 million shares of common stock and 25 million shares of undesignated preferred stock.

AI Assistant

CAMP4 THERAPEUTICS CORP

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.